SEK239.50
9.96% yesterday
Stockholm, Feb 21, 05:29 pm CET
ISIN
SE0000135485
Symbol
RAY B

RaySearch Laboratories Stock price

SEK239.50
+11.50 5.04% 1M
+90.90 61.17% 6M
+23.50 10.88% YTD
+152.88 176.49% 1Y
+198.52 484.41% 3Y
+148.96 164.53% 5Y
+170.62 247.70% 10Y
Stockholm, Closing price Fri, Feb 21 2025
-26.50 9.96%
ISIN
SE0000135485
Symbol
RAY B

Key metrics

Market capitalization SEK8.21b
Enterprise Value SEK8.22b
P/E (TTM) P/E ratio 46.90
EV/FCF (TTM) EV/FCF 17.42
EV/Sales (TTM) EV/Sales 6.90
P/S ratio (TTM) P/S ratio 6.89
P/B ratio (TTM) P/B ratio 10.13
Dividend yield 1.25%
Last dividend (FY24) SEK3.00
Revenue growth (TTM) Revenue growth 16.62%
Revenue (TTM) Revenue SEK1.19b
EBIT (operating result TTM) EBIT SEK246.98m
Free Cash Flow (TTM) Free Cash Flow SEK471.97m
Cash position SEK462.74m
EPS (TTM) EPS SEK5.94
P/E forward 35.53
P/S forward 6.14
EV/Sales forward 6.15
Show more

Is RaySearch Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,815 stocks worldwide.

RaySearch Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast RaySearch Laboratories:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast RaySearch Laboratories:

Buy
100%

Financial data from RaySearch Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,192 1,192
17% 17%
100%
- Direct Costs 173 173
50% 50%
14%
1,093 1,093
62% 62%
92%
- Selling and Administrative Expenses 503 503
543% 543%
42%
- Research and Development Expense 269 269
13% 13%
23%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 247 247
105% 105%
21%
Net Profit 204 204
149% 149%
17%

In millions SEK.

Don't miss a Thing! We will send you all news about RaySearch Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research. RayStation is the company's proprietary treatment planning system. Partner Products include proton and intensity modulated radiation therapy, automatic treatment planning, quality assurance, and radiobiology. Research offers long term study of new methods and techniques in radiation treatment. The company was founded by Johan Löf, Erik Hedlund, Carl Filip Bergendal, Anders Brahme, Bengt Lind, and Anders Liander in 2000 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Johan Löf
Employees 416
Founded 2000
Website www.raysearchlabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today